April 2024
1. ASANTE KP, Mathanga DP, Milligan P, Akech S, et al
   Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.
   Lancet. 2024 Apr 4:S0140-6736(24)00004-7. doi: 10.1016/S0140-6736(24)00004.
   

   >> Share

   
   
2. DAUBENBERGER CA, Silva JC
   First-generation malaria vaccine successfully implemented in three African countries.
   Lancet. 2024 Apr 4:S0140-6736(23)02892-1. doi: 10.1016/S0140-6736(23)02892.
   

   >> Share

   
   February 2024
3. THE LANCET
   Malaria vaccines: a test for global health.
   Lancet. 2024;403:503.
   

   >> Share

   
   
4. ADEPOJU P
   Routine malaria vaccinations begin.
   Lancet. 2024;403:423.
   

   >> Share

   
   
5. MOORTHY V, Hamel MJ, Smith PG
   Malaria vaccines for children: and now there are two.
   Lancet. 2024 Feb 1:S0140-6736(23)02743-5. doi: 10.1016/S0140-6736(23)02743.
   

   >> Share

   
   
6. DATOO MS, Dicko A, Tinto H, Ouedraogo JB, et al
   Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
   Lancet. 2024 Feb 1:S0140-6736(23)02511-4. doi: 10.1016/S0140-6736(23)02511.
   

   >> Share

   
   January 2024
7. NAKWEYA G
   Cabo Verde eliminates malaria.
   Lancet. 2024;403:341.
   

   >> Share

   
   
8. KAMYA MR, Kakuru A, Dorsey G
   Dihydroartemisinin-piperaquine for prevention of malaria in pregnant women living with HIV.
   Lancet. 2024 Jan 12:S0140-6736(24)00048-5. doi: 10.1016/S0140-6736(24)00048.
   

   >> Share

   
   
9. BARSOSIO HC, Madanitsa M, Ondieki ED, Dodd J, et al
   Chemoprevention for malaria with monthly intermittent preventive treatment with dihydroartemisinin-piperaquine in pregnant women living with HIV on daily co-trimoxazole in Kenya and Malawi: a randomised, double-blind, placebo-controlled trial.
   Lancet. 2024 Jan 12:S0140-6736(23)02631-4. doi: 10.1016/S0140-6736(23)02631.
   

   >> Share

   
   November 2023
10. ASSEFA A, Parr JB
    Universal radical cure: prospects and challenges for malaria elimination.
    Lancet. 2023 Nov 15:S0140-6736(23)01950-5. doi: 10.1016/S0140-6736(23)01950.
    

    >> Share

    
    
11. THRIEMER K, Degaga TS, Christian M, Alam MS, et al
    Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Lancet. 2023 Nov 15:S0140-6736(23)01553-2. doi: 10.1016/S0140-6736(23)01553.
    

    >> Share

    
    
12. POESPOPRODJO JR, Douglas NM, Ansong D, Kho S, et al
    Malaria.
    Lancet. 2023 Nov 1:S0140-6736(23)01249-7. doi: 10.1016/S0140-6736(23)01249.
    

    >> Share

    
    October 2023
13. ADEPOJU P
    Malaria community welcomes WHO vaccine approval.
    Lancet. 2023;402:1316.
    

    >> Share

    
    September 2023
14. KESSY SA, Tibenderana JR
    Zanzibar's malaria elimination efforts: progress, challenges, and lessons.
    Lancet. 2023;402:774.
    

    >> Share

    
    
15. HAWLEY WA, Laihad FJ, Ochomo E, Achee NL, et al
    What constitutes high-quality evidence for malaria vector control?
    Lancet. 2023;402:773-774.
    

    >> Share

    
    July 2023
16. SAMARASEKERA U
    Climate change and malaria: predictions becoming reality.
    Lancet. 2023;402:361-362.
    

    >> Share

    
    
17. DEVI S
    12 countries to get first doses of malaria vaccine.
    Lancet. 2023;402:172.
    

    >> Share

    
    May 2023
18. ZAROCOSTAS J
    Gavi unveils malaria vaccine plans.
    Lancet. 2023;401:1485.
    

    >> Share

    
    April 2023
19. KEATING C
    Artesunate versus quinine: the controlled trials watershed.
    Lancet. 2023;401:1329-1331.
    

    >> Share

    
    
20. PASRICHA SR, Mwangi MN, Moya E, Ataide R, et al
    Ferric carboxymaltose versus standard-of-care oral iron to treat second-trimester anaemia in Malawian pregnant women: a randomised controlled trial.
    Lancet. 2023 Apr 20:S0140-6736(23)00278-7. doi: 10.1016/S0140-6736(23)00278.
    

    >> Share

    
    March 2023
21. KAKURU A, Jagannathan P
    Can we reduce malaria in pregnancy and improve birth outcomes?
    Lancet. 2023 Mar 10:S0140-6736(23)00101-0. doi: 10.1016/S0140-6736(23)00101.
    

    >> Share

    
    January 2023
22. ACCROMBESSI M, Cook J, Dangbenon E, Yovogan B, et al
    Efficacy of pyriproxyfen-pyrethroid long-lasting insecticidal nets (LLINs) and chlorfenapyr-pyrethroid LLINs compared with pyrethroid-only LLINs for malaria control in Benin: a cluster-randomised, superiority trial.
    Lancet. 2023 Jan 24:S0140-6736(22)02319-4. doi: 10.1016/S0140-6736(22)02319.
    

    >> Share

    
    
23. KILLEEN GF, Sougoufara S
    Getting ahead of insecticide-resistant malaria vector mosquitoes.
    Lancet. 2023 Jan 24:S0140-6736(23)00102-2. doi: 10.1016/S0140-6736(23)00102.
    

    >> Share

    
    November 2022
24. SLUTSKER L, Leke RGF
    First-trimester use of ACTs for malaria treatment in pregnancy.
    Lancet. 2022 Nov 25:S0140-6736(22)02166-3. doi: 10.1016/S0140-6736(22)02166.
    

    >> Share

    
    
25. SAITO M, McGready R, Tinto H, Rouamba T, et al
    Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis.
    Lancet. 2022 Nov 25:S0140-6736(22)01881-5. doi: 10.1016/S0140-6736(22)01881.
    

    >> Share

    
    September 2022
26. WHITE NJ, Watson JA, Uyoga S, Williams TN, et al
    Substantial misdiagnosis of severe malaria in African children.
    Lancet. 2022;400:807.
    

    >> Share

    
    April 2022
27. THE LANCET
    Malaria in 2022: a year of opportunity.
    Lancet. 2022;399:1573.
    

    >> Share

    
    
28. NOOR AM, Alonso PL
    The message on malaria is clear: progress has stalled.
    Lancet. 2022 Apr 21. pii: S0140-6736(22)00732.
    

    >> Share

    
    March 2022
29. MOSHA JF, Kulkarni MA, Lukole E, Matowo NS, et al
    Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial.
    Lancet. 2022;399:1227-1241.
    

    >> Share

    
    February 2022
30. WHITE NJ, Day NPJ, Ashley EA, Smithuis FM, et al
    Have we really failed to roll back malaria?
    Lancet. 2022;399:799-800.
    

    >> Share

    
    January 2022
31. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    

    >> Share

    
    December 2021
32. VAN DER PLUIJM RW, Phyo AP, Lek D, White NJ, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
    Lancet. 2021;396:1976-1977.
    

    >> Share

    
    
33. WANG J, Xu C, Wong YK, Ma N, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution.
    Lancet. 2021;396:1976.
    

    >> Share

    
    
34. HOSSEINPOOR AR, Bergen N, Kirkby K, Schlotheuber A, et al
    Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria.
    Lancet. 2021 Dec 8. pii: S0140-6736(21)02756.
    

    >> Share

    
    October 2021
35. SAMARASEKERA U
    Cautious optimism for malaria vaccine roll-out.
    Lancet. 2021;398:1394.
    

    >> Share

    
    
36. THE LANCET
    Malaria vaccine approval: a step change for global health.
    Lancet. 2021;398:1381.
    

    >> Share

    
    May 2021
37. MOORTHY V, Binka F
    R21/Matrix-M: a second malaria vaccine?
    Lancet. 2021 May 5. pii: S0140-6736(21)01065.
    

    >> Share

    
    
38. DATOO MS, Natama MH, Some A, Traore O, et al
    Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
    Lancet. 2021 May 5. pii: S0140-6736(21)00943.
    

    >> Share

    
    April 2021
39. LANE R
    Faith Osier: inspirational immunologist.
    Lancet. 2021;397:1533.
    

    >> Share

    
    March 2021
40. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    

    >> Share

    
    February 2021
41. BATH D, Cook J, Govere J, Mathebula P, et al
    Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa.
    Lancet. 2021;397:816-827.
    

    >> Share

    
    
42. STERNBERG ED, Cook J, Alou LPA, Assi SB, et al
    Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Cote d'Ivoire: a two-arm, cluster-randomised controlled trial.
    Lancet. 2021;397:805-815.
    

    >> Share

    
    
43. HSIANG MS, Mumbengegwi D, Chimumbwa J
    Mini-outbreak response for malaria using indoor residual spraying.
    Lancet. 2021;397:771-773.
    

    >> Share

    
    
44. CHANDA E
    Averting malaria transmission with lethal house lure intervention.
    Lancet. 2021;397:769-771.
    

    >> Share

    
    December 2020
45. 
    Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    Lancet. 2020;396:1829-1840.
    

    >> Share

    
    
46. ASHLEY EA, Yeka A
    Seasonal malaria chemoprevention: closing the know-do gap.
    Lancet. 2020;396:1778-1779.
    

    >> Share

    
    November 2020
47. MAKONI M
    Violence leads to health emergencies in Mozambique.
    Lancet. 2020;396:1621.
    

    >> Share

    
    April 2020
48. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share